Opus Genetics, Inc. (IRD) Free cash flow 2019–2020
Opus Genetics, Inc. (IRD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.8MFY2020 · since FY2019: -$3.6M → -$6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$6.8M | -87.9% |
| FY2019 | -$3.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice